332 related articles for article (PubMed ID: 1371722)
1. Discordant results in human chorionic gonadotropin assays.
Cole LA; Kardana A
Clin Chem; 1992 Feb; 38(2):263-70. PubMed ID: 1371722
[TBL] [Abstract][Full Text] [Related]
2. Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free beta-subunit.
Kardana A; Cole LA
Clin Chem; 1992 Jan; 38(1):26-33. PubMed ID: 1370771
[TBL] [Abstract][Full Text] [Related]
3. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
[TBL] [Abstract][Full Text] [Related]
4. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to the free beta-subunit of human chorionic gonadotropin define three distinct antigenic domains and distinguish between intact and nicked molecules.
Bidart JM; Troalen F; Lazar V; Berger P; Marcillac I; Lhomme C; Droz JP; Bellet D
Endocrinology; 1992 Oct; 131(4):1832-40. PubMed ID: 1382962
[TBL] [Abstract][Full Text] [Related]
7. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites.
Cole LA
Clin Chem; 1997 Dec; 43(12):2233-43. PubMed ID: 9439438
[TBL] [Abstract][Full Text] [Related]
8. The biological and clinical significance of nicks in human chorionic gonadotropin and its free beta-subunit.
Cole LA; Kardana A; Ying FC; Birken S
Yale J Biol Med; 1991; 64(6):627-37. PubMed ID: 1725683
[TBL] [Abstract][Full Text] [Related]
9. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
[TBL] [Abstract][Full Text] [Related]
10. Clinical comparison of immunoradiometric assays for intact versus beta-specific human chorionic gonadotropin.
Pardue MG; Taylor EH; London S; Walls RC; Pappas AA
Am J Clin Pathol; 1990 Mar; 93(3):347-51. PubMed ID: 1689940
[TBL] [Abstract][Full Text] [Related]
11. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG.
Cole LA; Kardana A; Andrade-Gordon P; Gawinowicz MA; Morris JC; Bergert ER; O'Connor J; Birken S
Endocrinology; 1991 Sep; 129(3):1559-67. PubMed ID: 1714836
[TBL] [Abstract][Full Text] [Related]
12. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
Norman RJ; Buck RH; Joubert SM
S Afr Med J; 1989 Apr; 75(7):318-9. PubMed ID: 2538933
[TBL] [Abstract][Full Text] [Related]
13. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
Ozturk M
J Reprod Med; 1991 Jan; 36(1):21-6. PubMed ID: 1706779
[TBL] [Abstract][Full Text] [Related]
14. Histological origins of discordant chorionic gonadotropin secretion in malignancy.
Hay DL
J Clin Endocrinol Metab; 1988 Mar; 66(3):557-64. PubMed ID: 2450890
[TBL] [Abstract][Full Text] [Related]
15. Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit.
Badonnel Y; Barbé F; Legagneur H; Poncelet E; Schweitzer M
Clin Endocrinol (Oxf); 1994 Aug; 41(2):155-62. PubMed ID: 7523000
[TBL] [Abstract][Full Text] [Related]
16. The heterogeneity of human chorionic gonadotropin (hCG). I. Characterization of peptide heterogeneity in 13 individual preparations of hCG.
Kardana A; Elliott MM; Gawinowicz MA; Birken S; Cole LA
Endocrinology; 1991 Sep; 129(3):1541-50. PubMed ID: 1874187
[TBL] [Abstract][Full Text] [Related]
17. Immunoassays for quantifying choriogonadotropin compared for assay performance and clinical application.
Witherspoon LR; Shuler SE; Joseph GF; Baird EF; Neely HR; Sonnemaker RE
Clin Chem; 1992 Jun; 38(6):887-94. PubMed ID: 1375877
[TBL] [Abstract][Full Text] [Related]
18. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
[TBL] [Abstract][Full Text] [Related]
19. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
Rotmensch J; Rosenshein NB; Block BS
Gynecol Oncol; 1988 Jan; 29(1):82-6. PubMed ID: 2448190
[TBL] [Abstract][Full Text] [Related]
20. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
Sakuragi N
Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
[No Abstract] [Full Text] [Related]
[Next] [New Search]
